Turn Therapeutics Inc. Stock Analysis & AI Score
Turn Therapeutics Inc. (TTRX) has an ST Score of 28.6 (C-), driven by its Momentum (A-) and held back by its Growth (D-). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Turn Therapeutics Inc. (TTRX) has an ST Score of 28.6 (C-), driven by its Momentum (A-) and held back by its Growth (D-). Analysts rate it Buy.
- Strongest
- MomentumA-
- Weakest
- GrowthD-
All factor grades
- MomentumA-
- ValuationB-
- ProfitabilityD
- Financial StrengthD-
- GrowthD-
- Piotroski1/9
Contact
TTRX stock: frequently asked questions
What is TTRX's ST Score?
Turn Therapeutics Inc. (TTRX) has an ST Score of 28.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TTRX a buy, hold, or sell?
Analysts rate TTRX a Buy. Our ST Score grades it C- (28.6/100). The ST Score is a data-driven signal, not a recommendation.
What are TTRX's factor grades?
Valuation B-, Profitability D, Financial Strength D-, Momentum A-, Growth D-.
What is TTRX's valuation grade?
Turn Therapeutics Inc. (TTRX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TTRX's growth grade?
Turn Therapeutics Inc. (TTRX) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TTRX's profitability grade?
Turn Therapeutics Inc. (TTRX) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TTRX's financial strength grade?
Turn Therapeutics Inc. (TTRX) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is TTRX's Piotroski score?
Turn Therapeutics Inc. (TTRX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.